Empirical Financial Services LLC held its position in Danaher Corporation (NYSE:DHR) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,490 shares of the conglomerate’s stock at the end of the 2nd quarter. Empirical Financial Services LLC’s holdings in Danaher Corporation were worth $295,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. IFM Investors Pty Ltd bought a new stake in Danaher Corporation in the second quarter valued at about $1,441,000. Dillon & Associates Inc. increased its stake in Danaher Corporation by 12.5% in the second quarter. Dillon & Associates Inc. now owns 39,332 shares of the conglomerate’s stock valued at $3,304,000 after acquiring an additional 4,376 shares during the period. Polaris Greystone Financial Group LLC increased its stake in Danaher Corporation by 1.2% in the second quarter. Polaris Greystone Financial Group LLC now owns 235,824 shares of the conglomerate’s stock valued at $19,901,000 after acquiring an additional 2,835 shares during the period. Fiduciary Trust Co. increased its stake in Danaher Corporation by 16.8% in the second quarter. Fiduciary Trust Co. now owns 13,727 shares of the conglomerate’s stock valued at $1,158,000 after acquiring an additional 1,971 shares during the period. Finally, AGF Investments America Inc. increased its stake in Danaher Corporation by 29.6% in the second quarter. AGF Investments America Inc. now owns 116,216 shares of the conglomerate’s stock valued at $9,807,000 after acquiring an additional 26,535 shares during the period. 75.69% of the stock is currently owned by institutional investors and hedge funds.
COPYRIGHT VIOLATION WARNING: This article was first published by Community Financial News and is the sole property of of Community Financial News. If you are reading this article on another site, it was stolen and reposted in violation of U.S. and international trademark and copyright legislation. The legal version of this article can be viewed at https://www.com-unik.info/2017/10/12/danaher-corporation-dhr-position-held-by-empirical-financial-services-llc.html.
In related news, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of Danaher Corporation stock in a transaction that occurred on Monday, July 31st. The shares were sold at an average price of $81.78, for a total transaction of $799,154.16. Following the sale, the insider now directly owns 155,520 shares of the company’s stock, valued at approximately $12,718,425.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Linda P. Hefner sold 10,578 shares of Danaher Corporation stock in a transaction that occurred on Friday, July 21st. The shares were sold at an average price of $83.03, for a total transaction of $878,291.34. Following the sale, the director now directly owns 42,151 shares in the company, valued at $3,499,797.53. The disclosure for this sale can be found here. Insiders have sold a total of 71,496 shares of company stock worth $5,916,223 over the last ninety days. 12.20% of the stock is currently owned by insiders.
Danaher Corporation (DHR) opened at 86.96 on Thursday. The stock’s 50 day moving average is $85.55 and its 200-day moving average is $84.19. The firm has a market capitalization of $60.41 billion, a price-to-earnings ratio of 27.76 and a beta of 1.03. Danaher Corporation has a 12 month low of $75.71 and a 12 month high of $88.62.
Danaher Corporation (NYSE:DHR) last announced its quarterly earnings results on Thursday, July 20th. The conglomerate reported $0.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.97 by $0.02. The company had revenue of $4.51 billion for the quarter, compared to analyst estimates of $4.50 billion. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The firm’s revenue was up 6.3% on a year-over-year basis. During the same period in the previous year, the firm posted $0.90 EPS. Equities analysts anticipate that Danaher Corporation will post $3.96 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, September 29th will be issued a dividend of $0.14 per share. This represents a $0.56 annualized dividend and a dividend yield of 0.64%. The ex-dividend date of this dividend is Thursday, September 28th. Danaher Corporation’s dividend payout ratio (DPR) is presently 17.83%.
A number of analysts recently weighed in on the stock. Morgan Stanley reissued an “overweight” rating and issued a $95.00 target price (up previously from $86.00) on shares of Danaher Corporation in a research note on Friday, October 6th. Cowen and Company reissued a “buy” rating and issued a $90.00 target price on shares of Danaher Corporation in a research note on Wednesday, October 4th. Wells Fargo & Company assumed coverage on shares of Danaher Corporation in a research note on Thursday, July 13th. They issued a “market perform” rating and a $90.00 target price on the stock. Goldman Sachs Group, Inc. (The) reissued a “neutral” rating and issued a $83.00 target price on shares of Danaher Corporation in a research note on Tuesday, September 26th. Finally, Jefferies Group LLC reissued a “buy” rating and issued a $95.00 target price on shares of Danaher Corporation in a research note on Friday, August 4th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, twelve have given a buy rating and one has given a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $92.62.
Danaher Corporation Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).
What are top analysts saying about Danaher Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Danaher Corporation and related companies.